메뉴 건너뛰기




Volumn 4, Issue 5, 2009, Pages 541-555

Neurodegenerative disorders and nanoformulated drug development

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Fullerene; Nanomedicine; Nanoparticles; Neurodegeneration; Neuroregeneration; Parkinson's disease; Stroke

Indexed keywords

2 METHYL N (2 AMINOETHYL) 3 HYDROXYL 4 PYRIDINONE; AMYLOID BETA PROTEIN; BETA INTERFERON; BROMOCRIPTINE; CERIUM OXIDE; CHELATING AGENT; CHITOSAN; COPPER; DEFEROXAMINE; DENDRIMER; FULLERENE; FULLERENE DERIVATIVE; GLATIRAMER; HUPERZINE A; HYDRALAZINE; MONOCLONAL ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NANOCARRIER; NANOPARTICLE; PENICILLAMINE; PHOSPHATIDYLGLYCEROL; POLY(BUTYLCYANOACRYLATE) NANOPARTICLE; POLYGLACTIN; POLYSORBATE 80; POLYSTYRENE; SIALIC ACID; SUPEROXIDE DISMUTASE; TACRINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VP 025;

EID: 68249158658     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.09.37     Document Type: Review
Times cited : (65)

References (161)
  • 3
    • 62149099593 scopus 로고    scopus 로고
    • Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review
    • Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 8(4), 355-369 (2009).
    • (2009) Lancet Neurol , vol.8 , Issue.4 , pp. 355-369
    • Feigin, V.L.1    Lawes, C.M.2    Bennett, D.A.3    Barker-Collo, S.L.4    Parag, V.5
  • 5
    • 33744490350 scopus 로고    scopus 로고
    • Epidemiology and natural history of multiple sclerosis: New insights
    • Kantarci O, Wingerchuk D: Epidemiology and natural history of multiple sclerosis: new insights; Curr. Opin. Neurol. 19(3), 248-254 (2006).
    • (2006) Curr. Opin. Neurol , vol.19 , Issue.3 , pp. 248-254
    • Kantarci, O.1    Wingerchuk, D.2
  • 6
    • 33748966989 scopus 로고    scopus 로고
    • Epidemiology of neuroimmunological diseases
    • Flachenecker P: Epidemiology of neuroimmunological diseases. J. Neurol. 253(Suppl. 5), V2-V8 (2006).
    • (2006) J. Neurol , vol.253 , Issue.SUPPL. 5
    • Flachenecker, P.1
  • 7
    • 0041856595 scopus 로고    scopus 로고
    • Epidemiology of neurodegeneration
    • Mayeux R: Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 26, 81-104 (2003).
    • (2003) Annu. Rev. Neurosci , vol.26 , pp. 81-104
    • Mayeux, R.1
  • 8
    • 33646234244 scopus 로고    scopus 로고
    • Approaches to palliative therapies for Alzheimer's disease
    • Robichaud AJ: Approaches to palliative therapies for Alzheimer's disease. Curr. Top. Med. Chem. 6(6), 553-568 (2006).
    • (2006) Curr. Top. Med. Chem , vol.6 , Issue.6 , pp. 553-568
    • Robichaud, A.J.1
  • 9
    • 34248350692 scopus 로고    scopus 로고
    • Palliative care in a myotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis
    • Elman LB, Houghton DJ, Wu GF, Hurtig HI, Markowitz CE, McCluskey L: Palliative care in a myotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. J. Palliat. Med. 10(2), 433-457 (2007).
    • (2007) J. Palliat. Med , vol.10 , Issue.2 , pp. 433-457
    • Elman, L.B.1    Houghton, D.J.2    Wu, G.F.3    Hurtig, H.I.4    Markowitz, C.E.5    McCluskey, L.6
  • 11
    • 63849213978 scopus 로고    scopus 로고
    • Amyloid β-peptide aggregation. What does it result in and how can it be prevented?
    • Nerelius C, Johansson J, Sandegren A: Amyloid β-peptide aggregation. What does it result in and how can it be prevented? Front. Biosci. 14, 1716-1729 (2009).
    • (2009) Front. Biosci , vol.14 , pp. 1716-1729
    • Nerelius, C.1    Johansson, J.2    Sandegren, A.3
  • 12
    • 29044443820 scopus 로고    scopus 로고
    • Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease
    • Watson D, Castano E, Kokjohn TA et al.: Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease. Neurol. Res. 27(8), 869-881 (2005).
    • (2005) Neurol. Res , vol.27 , Issue.8 , pp. 869-881
    • Watson, D.1    Castano, E.2    Kokjohn, T.A.3
  • 13
    • 66049147738 scopus 로고    scopus 로고
    • The complexity of neurobiological processes in acute ischemic stroke
    • Brouns R, De Deyn PP: The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 111(6), 483-495 (2009).
    • (2009) Clin. Neurol. Neurosurg , vol.111 , Issue.6 , pp. 483-495
    • Brouns, R.1    De Deyn, P.P.2
  • 16
    • 33645046630 scopus 로고    scopus 로고
    • Potential therapeutic targets in the NF-κB pathway for Alzheimer's disease
    • Collister KA, Albensi BC: Potential therapeutic targets in the NF-κB pathway for Alzheimer's disease. Drug News Perspect. 18(10), 623-629 (2005).
    • (2005) Drug News Perspect , vol.18 , Issue.10 , pp. 623-629
    • Collister, K.A.1    Albensi, B.C.2
  • 17
    • 33645867989 scopus 로고    scopus 로고
    • Therapeutic targets for amyotrophic lateral sclerosis: Current treatments and prospects for more-effective therapies
    • Bruijn LI, Cudkowicz M: Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more-effective therapies. Expert Rev. Neurother. 6(3), 417-428 (2006).
    • (2006) Expert Rev. Neurother , vol.6 , Issue.3 , pp. 417-428
    • Bruijn, L.I.1    Cudkowicz, M.2
  • 18
    • 33646555181 scopus 로고    scopus 로고
    • CNS gene therapy and a nexus of complexity: Systems and biology at a crossroads
    • Tyler CM, Federoff HJ: CNS gene therapy and a nexus of complexity: systems and biology at a crossroads. Cell Transplant. 15(3), 267-273 (2006).
    • (2006) Cell Transplant , vol.15 , Issue.3 , pp. 267-273
    • Tyler, C.M.1    Federoff, H.J.2
  • 19
    • 67349195578 scopus 로고    scopus 로고
    • Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes
    • Weimer DL, Sager MA: Early identification and treatment of Alzheimer's disease: social and fiscal outcomes. Alzheimers Dement. 5(3), 215-226 (2009).
    • (2009) Alzheimers Dement , vol.5 , Issue.3 , pp. 215-226
    • Weimer, D.L.1    Sager, M.A.2
  • 20
    • 67749118071 scopus 로고    scopus 로고
    • Querbes O, Aubry F, Pariente J et al.: Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain (2009).
    • Querbes O, Aubry F, Pariente J et al.: Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain (2009).
  • 21
    • 67651152993 scopus 로고    scopus 로고
    • Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia
    • Listerud J, Powers C, Moore P, Libon DJ, Grossman M: Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia. J. Int. Neuropsychol Soc. 15(3), 459-470 (2009).
    • (2009) J. Int. Neuropsychol Soc , vol.15 , Issue.3 , pp. 459-470
    • Listerud, J.1    Powers, C.2    Moore, P.3    Libon, D.J.4    Grossman, M.5
  • 22
    • 64549096827 scopus 로고    scopus 로고
    • Structural and functional MRI in mild cognitive impairment
    • Pihlajamaki M, Jauhiainen AM, Soininen H: Structural and functional MRI in mild cognitive impairment. Curr. Alzheimer Res. 6(2), 179-185 (2009).
    • (2009) Curr. Alzheimer Res , vol.6 , Issue.2 , pp. 179-185
    • Pihlajamaki, M.1    Jauhiainen, A.M.2    Soininen, H.3
  • 24
    • 32944472598 scopus 로고    scopus 로고
    • Frontotemporal dementia - Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology
    • Galariotis V, Bodi N, Janka Z, Kalman J: Frontotemporal dementia - Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology. Ideggyogy. Sz. 58(7-8), 220-224 (2005).
    • (2005) Ideggyogy. Sz , vol.58 , Issue.7-8 , pp. 220-224
    • Galariotis, V.1    Bodi, N.2    Janka, Z.3    Kalman, J.4
  • 25
    • 33751245916 scopus 로고    scopus 로고
    • Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: The Geneva experience
    • Giannakopoulos P, Gold G, Kovari E et al.: Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol. 113(1), 1-12 (2007).
    • (2007) Acta Neuropathol , vol.113 , Issue.1 , pp. 1-12
    • Giannakopoulos, P.1    Gold, G.2    Kovari, E.3
  • 27
    • 63449094460 scopus 로고    scopus 로고
    • Molecular pathogenesis of Alzheimer's disease: Reductionist versus expansionist approaches
    • Castellani RJ, Zhu X, Lee HG, Smith MA, Perry G: Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches. Int. J. Mol. Sci. 10(3), 1386-1406 (2009).
    • (2009) Int. J. Mol. Sci , vol.10 , Issue.3 , pp. 1386-1406
    • Castellani, R.J.1    Zhu, X.2    Lee, H.G.3    Smith, M.A.4    Perry, G.5
  • 29
    • 61849185913 scopus 로고    scopus 로고
    • Recent developments in Alzheimer's disease therapeutics
    • Rafii MS, Aisen PS: Recent developments in Alzheimer's disease therapeutics. BMC Med. 7, 7 (2009).
    • (2009) BMC Med , vol.7 , pp. 7
    • Rafii, M.S.1    Aisen, P.S.2
  • 30
    • 33750082029 scopus 로고    scopus 로고
    • Disease modifying therapy for AD?
    • Golde TE: Disease modifying therapy for AD? J. Neurochem. 99(3), 689-707 (2006).
    • (2006) J. Neurochem , vol.99 , Issue.3 , pp. 689-707
    • Golde, T.E.1
  • 31
    • 54249156984 scopus 로고    scopus 로고
    • Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies
    • Sigurdsson EM: Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies. J. Alzheimer Dis. 15(2), 157-168 (2008).
    • (2008) J. Alzheimer Dis , vol.15 , Issue.2 , pp. 157-168
    • Sigurdsson, E.M.1
  • 32
    • 59149107151 scopus 로고    scopus 로고
    • Neurotrophic support and oxidative stress: Converging effects in the normal and diseased nervous system
    • Gardiner J, Barton D, Overall R, Marc J: Neurotrophic support and oxidative stress: converging effects in the normal and diseased nervous system. Neuroscientist 15(1), 47-61 (2009).
    • (2009) Neuroscientist , vol.15 , Issue.1 , pp. 47-61
    • Gardiner, J.1    Barton, D.2    Overall, R.3    Marc, J.4
  • 33
    • 57449110125 scopus 로고    scopus 로고
    • NADPH oxidase as a therapeutic target in Alzheimer's disease
    • S
    • Block ML: NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci. 9(Suppl. 2), S8 (2008).
    • (2008) BMC Neurosci , vol.9 , Issue.SUPPL. 2 , pp. 8
    • Block, M.L.1
  • 34
    • 36549083642 scopus 로고    scopus 로고
    • Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease
    • Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB: Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch. Med. Res. 39(1), 1-16 (2008).
    • (2008) Arch. Med. Res , vol.39 , Issue.1 , pp. 1-16
    • Rojo, L.E.1    Fernandez, J.A.2    Maccioni, A.A.3    Jimenez, J.M.4    Maccioni, R.B.5
  • 35
    • 44849092655 scopus 로고    scopus 로고
    • Nanotechnology solutions for Alzheimer's disease: Advances in research tools, diagnostic methods and therapeutic agents
    • Nazem A, Mansoori GA: Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents. J. Alzheimers Dis. 13(2), 199-223 (2008).
    • (2008) J. Alzheimers Dis , vol.13 , Issue.2 , pp. 199-223
    • Nazem, A.1    Mansoori, G.A.2
  • 37
    • 0033964859 scopus 로고    scopus 로고
    • In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
    • Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA: In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74(1), 270-279 (2000).
    • (2000) J. Neurochem , vol.74 , Issue.1 , pp. 270-279
    • Sayre, L.M.1    Perry, G.2    Harris, P.L.3    Liu, Y.4    Schubert, K.A.5    Smith, M.A.6
  • 38
  • 39
    • 0027980901 scopus 로고
    • Rapid induction of Alzheimer Aβ amyloid formation by zinc
    • Bush AI, Pettingell WH, Multhaup G et al.: Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265(5177), 1464-1467 (1994).
    • (1994) Science , vol.265 , Issue.5177 , pp. 1464-1467
    • Bush, A.I.1    Pettingell, W.H.2    Multhaup, G.3
  • 40
    • 0028177269 scopus 로고
    • The βA4 amyloid precursor protein binding to copper
    • Hesse L, Beher D, Masters CL, Multhaup G: The βA4 amyloid precursor protein binding to copper. FEBS Lett. 349(1), 109-116 (1994).
    • (1994) FEBS Lett , vol.349 , Issue.1 , pp. 109-116
    • Hesse, L.1    Beher, D.2    Masters, C.L.3    Multhaup, G.4
  • 41
    • 0028031808 scopus 로고
    • Effects of chelators on iron uptake and release by the brain in the rat
    • Crowe A, Morgan EH: Effects of chelators on iron uptake and release by the brain in the rat. Neurochem. Res. 19(1), 71-76 (1994).
    • (1994) Neurochem. Res , vol.19 , Issue.1 , pp. 71-76
    • Crowe, A.1    Morgan, E.H.2
  • 43
    • 34548406555 scopus 로고    scopus 로고
    • Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis
    • Marsh JN, Senpan A, Hu G et al.: Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomed. 2(4), 533-543 (2007).
    • (2007) Nanomed , vol.2 , Issue.4 , pp. 533-543
    • Marsh, J.N.1    Senpan, A.2    Hu, G.3
  • 44
    • 12344251715 scopus 로고    scopus 로고
    • Novel D- penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
    • Cui Z, Lockman PR, Atwbood CS et al.: Novel D- penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases. Eur. J. Pharm. Biopharm. 59(2), 263-272 (2005).
    • (2005) Eur. J. Pharm. Biopharm , vol.59 , Issue.2 , pp. 263-272
    • Cui, Z.1    Lockman, P.R.2    Atwbood, C.S.3
  • 45
    • 33748202940 scopus 로고    scopus 로고
    • Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
    • Liu G, Men P, Harris PL, Rolston RK, Perry G, Smith MA: Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci. Lett. 406(3), 189-193 (2006).
    • (2006) Neurosci. Lett , vol.406 , Issue.3 , pp. 189-193
    • Liu, G.1    Men, P.2    Harris, P.L.3    Rolston, R.K.4    Perry, G.5    Smith, M.A.6
  • 46
    • 64049104164 scopus 로고    scopus 로고
    • Nanoparticle - chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
    • Liu G, Men P, Kudo W, Perry G, Smith MA: Nanoparticle - chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neurosci. Lett. 455(3), 187-190 (2009).
    • (2009) Neurosci. Lett , vol.455 , Issue.3 , pp. 187-190
    • Liu, G.1    Men, P.2    Kudo, W.3    Perry, G.4    Smith, M.A.5
  • 47
    • 10744226316 scopus 로고    scopus 로고
    • Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice
    • Bayer TA, Schafer S, Simons A et al.: Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc. Natl Acad. Sci. USA 100(24), 14187-14192 (2003).
    • (2003) Proc. Natl Acad. Sci. USA , vol.100 , Issue.24 , pp. 14187-14192
    • Bayer, T.A.1    Schafer, S.2    Simons, A.3
  • 48
    • 2442586535 scopus 로고    scopus 로고
    • Copper depletion down-regulates expression of the Alzheimer's disease amyloid-β precursor protein gene
    • Bellingham SA, Lahiri DK, Maloney B, La Fontaine S, Multhaup G, Camakaris J: Copper depletion down-regulates expression of the Alzheimer's disease amyloid-β precursor protein gene. J. Biol. Chem. 279(19), 20378-20386 (2004).
    • (2004) J. Biol. Chem , vol.279 , Issue.19 , pp. 20378-20386
    • Bellingham, S.A.1    Lahiri, D.K.2    Maloney, B.3    La Fontaine, S.4    Multhaup, G.5    Camakaris, J.6
  • 49
    • 10744228112 scopus 로고    scopus 로고
    • In vivo reduction of amyloid-β by a mutant copper transporter
    • Phinney AL, Drisaldi B, Schmidt SD et al.: In vivo reduction of amyloid-β by a mutant copper transporter. Proc. Natl Acad. Sci. USA 100(24), 14193-14198 (2003).
    • (2003) Proc. Natl Acad. Sci. USA , vol.100 , Issue.24 , pp. 14193-14198
    • Phinney, A.L.1    Drisaldi, B.2    Schmidt, S.D.3
  • 50
    • 66149175672 scopus 로고    scopus 로고
    • Cellular copper import by nanocarrier systems, intracellular availability and effects on amyloid peptide secretion
    • Multhaup G, Treiber C, Quadir M et al.: Cellular copper import by nanocarrier systems, intracellular availability and effects on amyloid peptide secretion. Biochemistry 48(20), 4273-4284 (2009).
    • (2009) Biochemistry , vol.48 , Issue.20 , pp. 4273-4284
    • Multhaup, G.1    Treiber, C.2    Quadir, M.3
  • 51
    • 49749092065 scopus 로고    scopus 로고
    • Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: A pilot Phase 2 clinical trial
    • Kessler H, Bayer TA, Bach D et al.: Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot Phase 2 clinical trial. J. Neural Transm. 115(8), 1181-1187 (2008).
    • (2008) J. Neural Transm , vol.115 , Issue.8 , pp. 1181-1187
    • Kessler, H.1    Bayer, T.A.2    Bach, D.3
  • 52
    • 46149107512 scopus 로고    scopus 로고
    • Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
    • Adlard PA, Cherny RA, Finkelstein DI et al.: Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ. Neuron 59(1), 43-55 (2008).
    • (2008) Neuron , vol.59 , Issue.1 , pp. 43-55
    • Adlard, P.A.1    Cherny, R.A.2    Finkelstein, D.I.3
  • 53
    • 34249686578 scopus 로고    scopus 로고
    • Pro-apoptotic activity of novel isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage
    • Filomeni G, Cerchiaro G, Da Costa Ferreira AM et al.: Pro-apoptotic activity of novel isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage. J. Biol. Chem. 282(16), 12010-12021 (2007).
    • (2007) J. Biol. Chem , vol.282 , Issue.16 , pp. 12010-12021
    • Filomeni, G.1    Cerchiaro, G.2    Da Costa Ferreira, A.M.3
  • 54
    • 4644238758 scopus 로고    scopus 로고
    • The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice
    • Lee JY, Friedman JE, Angel I, Kozak A, Koh JY: The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice. Neurobiol. Aging 25(10), 1315-1321 (2004).
    • (2004) Neurobiol. Aging , vol.25 , Issue.10 , pp. 1315-1321
    • Lee, J.Y.1    Friedman, J.E.2    Angel, I.3    Kozak, A.4    Koh, J.Y.5
  • 55
    • 67349139416 scopus 로고    scopus 로고
    • Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid
    • Strozyk D, Launer LJ, Adlard PA et al.: Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid. Neurobiol. Aging 30(7), 1069-1077 (2007).
    • (2007) Neurobiol. Aging , vol.30 , Issue.7 , pp. 1069-1077
    • Strozyk, D.1    Launer, L.J.2    Adlard, P.A.3
  • 56
    • 36749044742 scopus 로고    scopus 로고
    • Zinc binding to amyloid-β: Isothermal titration calorimetry and Zn competition experiments with Zn sensors
    • Talmard C, Bouzan A, Faller P: Zinc binding to amyloid-β: isothermal titration calorimetry and Zn competition experiments with Zn sensors. Biochemistry 46(47), 13658-13666 (2007).
    • (2007) Biochemistry , vol.46 , Issue.47 , pp. 13658-13666
    • Talmard, C.1    Bouzan, A.2    Faller, P.3
  • 57
    • 51749106579 scopus 로고    scopus 로고
    • Abundant expression of zinc transporters in the amyloid, plaques of Alzheimer's disease brain
    • Zhang LH, Wang X, Stoltenberg M, Danscher G, Huang L, Wang ZY: Abundant expression of zinc transporters in the amyloid, plaques of Alzheimer's disease brain. Brain Res. Bull. 77(1), 55-60 (2008).
    • (2008) Brain Res. Bull , vol.77 , Issue.1 , pp. 55-60
    • Zhang, L.H.1    Wang, X.2    Stoltenberg, M.3    Danscher, G.4    Huang, L.5    Wang, Z.Y.6
  • 58
    • 34548130742 scopus 로고    scopus 로고
    • EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases
    • Klajnert B, Cangiotti M, Calici S et al.: EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases. Macromol. Biosci. 7(8), 1065-1074 (2007).
    • (2007) Macromol. Biosci , vol.7 , Issue.8 , pp. 1065-1074
    • Klajnert, B.1    Cangiotti, M.2    Calici, S.3
  • 59
    • 56449124781 scopus 로고    scopus 로고
    • Inhibition of amyloid β protein fibrillation by polymeric nanoparticles
    • Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I et al.: Inhibition of amyloid β protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 130(46), 15437-15443 (2008).
    • (2008) J. Am. Chem. Soc , vol.130 , Issue.46 , pp. 15437-15443
    • Cabaleiro-Lago, C.1    Quinlan-Pluck, F.2    Lynch, I.3
  • 60
    • 34447517643 scopus 로고    scopus 로고
    • 60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task
    • 60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task. J. Nanosci. Nanotechnol. 7(4-5), 1479-1485 (2007).
    • (2007) J. Nanosci. Nanotechnol , vol.7 , Issue.4-5 , pp. 1479-1485
    • Podolski, I.Y.1    Podlubnaya, Z.A.2    Kosenko, E.A.3
  • 61
    • 33750052628 scopus 로고    scopus 로고
    • PEGylated phospholipid nanomicelles interact with β-amyloid(1-42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro
    • Pai AS, Rubinstein I, Onyuksel H: PEGylated phospholipid nanomicelles interact with β-amyloid(1-42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro. Peptides 27(11), 2858-2866 (2006).
    • (2006) Peptides , vol.27 , Issue.11 , pp. 2858-2866
    • Pai, A.S.1    Rubinstein, I.2    Onyuksel, H.3
  • 62
    • 67650431678 scopus 로고    scopus 로고
    • Effect of maghemite nanoparticles on insulin amyloid fibril formation: Selective labeling, kinetics, and fibril removal by a magnetic field
    • Skaat H, Sorci M, Belfort G, Margel S: Effect of maghemite nanoparticles on insulin amyloid fibril formation: selective labeling, kinetics, and fibril removal by a magnetic field. J. Biomed. Mater. Res. A (2008).
    • (2008) J. Biomed. Mater. Res. A
    • Skaat, H.1    Sorci, M.2    Belfort, G.3    Margel, S.4
  • 63
    • 34447513070 scopus 로고    scopus 로고
    • Attenuation of β-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: Role of sialic acid attachment
    • Patel DA, Henry JE, Good TA: Attenuation of β-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: role of sialic acid attachment. Brain Res. 1161, 95-105 (2007).
    • (2007) Brain Res , vol.1161 , pp. 95-105
    • Patel, D.A.1    Henry, J.E.2    Good, T.A.3
  • 64
    • 33750626825 scopus 로고    scopus 로고
    • Attenuation of β-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers
    • Patel D, Henry J, Good T: Attenuation of β-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers. Biochim. Biophys. Acta 1760(12), 1802-1809 (2006).
    • (2006) Biochim. Biophys. Acta , vol.1760 , Issue.12 , pp. 1802-1809
    • Patel, D.1    Henry, J.2    Good, T.3
  • 65
    • 45749115053 scopus 로고    scopus 로고
    • How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils
    • Olmedo I, Araya E, Sanz F et al.: How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils. Bioconjug. Chem. 19(6), 1154-1163 (2008).
    • (2008) Bioconjug. Chem , vol.19 , Issue.6 , pp. 1154-1163
    • Olmedo, I.1    Araya, E.2    Sanz, F.3
  • 66
    • 42049091686 scopus 로고    scopus 로고
    • Photothermal ablation of amyloid aggregates by gold nanoparticles
    • Triulzi RC, Dai Q, Zou J et al.: Photothermal ablation of amyloid aggregates by gold nanoparticles. Colloids Surf. B Biointerfaces 63(2), 200-208 (2008).
    • (2008) Colloids Surf. B Biointerfaces , vol.63 , Issue.2 , pp. 200-208
    • Triulzi, R.C.1    Dai, Q.2    Zou, J.3
  • 67
    • 31544459915 scopus 로고    scopus 로고
    • Nanoparticle-mediated local and remote manipulation of protein aggregation
    • Kogan MJ, Bastus NG, Amigo R et al.: Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett. 6(1), 110-115 (2006).
    • (2006) Nano Lett , vol.6 , Issue.1 , pp. 110-115
    • Kogan, M.J.1    Bastus, N.G.2    Amigo, R.3
  • 68
    • 58149374037 scopus 로고    scopus 로고
    • Antioxidant therapy in Alzheimer's disease: Theory and practice
    • Aliev G, Obrenovich ME, Reddy VP et al.: Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev. Med. Chem. 8(13), 1395-1406 (2008).
    • (2008) Mini Rev. Med. Chem , vol.8 , Issue.13 , pp. 1395-1406
    • Aliev, G.1    Obrenovich, M.E.2    Reddy, V.P.3
  • 69
    • 55649106830 scopus 로고    scopus 로고
    • Targeting, reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease
    • Yokoyama H, Kuroiwa H, Yano R, Araki T: Targeting, reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease. Neurol. Sci. 29(5), 293-301 (2008).
    • (2008) Neurol. Sci , vol.29 , Issue.5 , pp. 293-301
    • Yokoyama, H.1    Kuroiwa, H.2    Yano, R.3    Araki, T.4
  • 70
    • 44949242548 scopus 로고    scopus 로고
    • Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice
    • Yokoyama H, Takagi S, Watanabe Y, Kato H, Araki T: Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. J. Neural Transm. 115(6), 831-842 (2008).
    • (2008) J. Neural Transm , vol.115 , Issue.6 , pp. 831-842
    • Yokoyama, H.1    Takagi, S.2    Watanabe, Y.3    Kato, H.4    Araki, T.5
  • 71
    • 58149498314 scopus 로고    scopus 로고
    • Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease
    • Wilson B, Samanta MK, Santhi K, Sampath Kumar KP, Ramasamy M, Suresh B: Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease. J. Neurosci. Methods 177(2), 427-433 (2009).
    • (2009) J. Neurosci. Methods , vol.177 , Issue.2 , pp. 427-433
    • Wilson, B.1    Samanta, M.K.2    Santhi, K.3    Sampath Kumar, K.P.4    Ramasamy, M.5    Suresh, B.6
  • 72
    • 34147092491 scopus 로고    scopus 로고
    • Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: In vitro and in vivo studies and the application in the treatment of the impaired memory of mice
    • Chu D, Tian J, Liu W, Li Z, Li Y: Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chem. Pharm. Bull. (Tokyo) 55(4), 625-628 (2007).
    • (2007) Chem. Pharm. Bull. (Tokyo) , vol.55 , Issue.4 , pp. 625-628
    • Chu, D.1    Tian, J.2    Liu, W.3    Li, Z.4    Li, Y.5
  • 73
    • 33847045172 scopus 로고    scopus 로고
    • Prolonged effects of poly(lactic-co-glycolic acid) microsphere-containing huperzine A on mouse memory dysfunction induced by scopolamine
    • Wang C, Zhang T, Ma H, Liu J, Fu F, Liu K: Prolonged effects of poly(lactic-co-glycolic acid) microsphere-containing huperzine A on mouse memory dysfunction induced by scopolamine. Basic Clin. Pharmacol. Toxicol. 100(3), 190-195 (2007).
    • (2007) Basic Clin. Pharmacol. Toxicol , vol.100 , Issue.3 , pp. 190-195
    • Wang, C.1    Zhang, T.2    Ma, H.3    Liu, J.4    Fu, F.5    Liu, K.6
  • 76
    • 58149147452 scopus 로고    scopus 로고
    • Ultra-sensitive immunosensor for β-amyloid (1-42) using scanning tunneling microscopy-based electrical detection
    • Kang DY, Lee JH, Oh BK, Choi JW: Ultra-sensitive immunosensor for β-amyloid (1-42) using scanning tunneling microscopy-based electrical detection. Biosens. Bioelectron. 24(5), 1431-1436 (2009).
    • (2009) Biosens. Bioelectron , vol.24 , Issue.5 , pp. 1431-1436
    • Kang, D.Y.1    Lee, J.H.2    Oh, B.K.3    Choi, J.W.4
  • 77
    • 37449000878 scopus 로고    scopus 로고
    • Detection of Alzheimer's tail protein using localised surface plasmon resonance-based immunochip
    • Vestergaard M, Kerman K, Kim DK, Ha MH, Tamiya E: Detection of Alzheimer's tail protein using localised surface plasmon resonance-based immunochip. Talanta 74(4), 1038-1042 (2008).
    • (2008) Talanta , vol.74 , Issue.4 , pp. 1038-1042
    • Vestergaard, M.1    Kerman, K.2    Kim, D.K.3    Ha, M.H.4    Tamiya, E.5
  • 78
    • 57049182374 scopus 로고    scopus 로고
    • Neuroanatomy and pathology of sporadic Parkinson's disease
    • Braak H, Del Tredici K: Neuroanatomy and pathology of sporadic Parkinson's disease. Adv. Anat. Embryol. Cell Biol. 201, 1-119 (2009).
    • (2009) Adv. Anat. Embryol. Cell Biol , vol.201 , pp. 1-119
    • Braak, H.1    Del Tredici, K.2
  • 79
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron 39(6), 889-909 (2003).
    • (2003) Neuron , vol.39 , Issue.6 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 80
    • 57649155208 scopus 로고    scopus 로고
    • Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance
    • Zhou C, Huang Y, Przedborski S: Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. NY Acad. Sci. 1147, 93-104 (2008).
    • (2008) Ann. NY Acad. Sci , vol.1147 , pp. 93-104
    • Zhou, C.1    Huang, Y.2    Przedborski, S.3
  • 81
    • 62549133546 scopus 로고    scopus 로고
    • Neuroinflammation in Parkinson's disease: A target for neuroprotection?
    • Hirsch EC, Hunot S: Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 8(4), 382-397 (2009).
    • (2009) Lancet Neurol , vol.8 , Issue.4 , pp. 382-397
    • Hirsch, E.C.1    Hunot, S.2
  • 82
    • 55249087467 scopus 로고
    • Immunological features of α-synuclein in Parkinson's disease
    • 2008
    • Roodveldt C, Christodoulou J, Dobson CM: Immunological features of α-synuclein in Parkinson's disease. J. Cell Mol. Med. 12(5B), 1820-1829 (2008).
    • (1820) J. Cell Mol. Med , Issue.5 B , pp. 12
    • Roodveldt, C.1    Christodoulou, J.2    Dobson, C.M.3
  • 83
    • 63149090431 scopus 로고    scopus 로고
    • Parkinson's disease: From monogenic forms to genetic susceptibility factors
    • Lesage S, Brice A: Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18(R1), R48-R59 (2009).
    • (2009) Hum. Mol. Genet , vol.18 , Issue.R1
    • Lesage, S.1    Brice, A.2
  • 84
    • 34447500085 scopus 로고    scopus 로고
    • Autonomic dysfunction in Parkinson's disease
    • Dubow JS: Autonomic dysfunction in Parkinson's disease. Dis. Mon. 53(5), 265-274 (2007).
    • (2007) Dis. Mon , vol.53 , Issue.5 , pp. 265-274
    • Dubow, J.S.1
  • 85
    • 17844365885 scopus 로고    scopus 로고
    • Symptoms of autonomic failure in Parkinson's disease: Prevalence and impact on daily life
    • Magerkurth C, Schnitzer R, Braune S: Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin. Auton. Res. 15(2), 76-82 (2005).
    • (2005) Clin. Auton. Res , vol.15 , Issue.2 , pp. 76-82
    • Magerkurth, C.1    Schnitzer, R.2    Braune, S.3
  • 87
    • 33845211714 scopus 로고    scopus 로고
    • Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease
    • Mosley RL, Benner EJ, Kadiu I et al.: Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease. Clin. Neurosci. Res. 6(5), 261-281 (2006).
    • (2006) Clin. Neurosci. Res , vol.6 , Issue.5 , pp. 261-281
    • Mosley, R.L.1    Benner, E.J.2    Kadiu, I.3
  • 92
    • 34548572856 scopus 로고    scopus 로고
    • Fullerenes in biology]
    • Krokosz A: [Fullerenes in biology]. Postepy Biochem. 53(1), 91-96 (2007).
    • (2007) Postepy Biochem , vol.53 , Issue.1 , pp. 91-96
    • Krokosz, A.1
  • 94
    • 42449127134 scopus 로고    scopus 로고
    • Toxicity studies of fullerenes and derivatives
    • Kolosnjaj J, Szwarc H, Moussa F: Toxicity studies of fullerenes and derivatives. Adv. Exp. Med. Biol. 620, 168-180 (2007).
    • (2007) Adv. Exp. Med. Biol , vol.620 , pp. 168-180
    • Kolosnjaj, J.1    Szwarc, H.2    Moussa, F.3
  • 96
    • 59349094291 scopus 로고    scopus 로고
    • +-induced cellular model of Parkinson's disease
    • +-induced cellular model of Parkinson's disease. J. Neurosci. Res. 86(16), 3622-3634 (2008).
    • (2008) J. Neurosci. Res , vol.86 , Issue.16 , pp. 3622-3634
    • Cai, X.1    Jia, H.2    Liu, Z.3
  • 97
    • 34547601983 scopus 로고    scopus 로고
    • Nanomedicine in the diagnosis and therapy of neurodegenerative disorders
    • Kabanov AV, Gendelman HE: Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci. 32, 1054-1082 (2007).
    • (2007) Prog. Polym. Sci , vol.32 , pp. 1054-1082
    • Kabanov, A.V.1    Gendelman, H.E.2
  • 98
    • 34648843409 scopus 로고    scopus 로고
    • A macrophage - nanozyme delivery system for Parkinson's disease
    • Batrakova EV, Li S, Reynolds AD et al.: A macrophage - nanozyme delivery system for Parkinson's disease. Bioconjug. Chem. 18(5), 1498-1506 (2007).
    • (2007) Bioconjug. Chem , vol.18 , Issue.5 , pp. 1498-1506
    • Batrakova, E.V.1    Li, S.2    Reynolds, A.D.3
  • 102
    • 0242414731 scopus 로고    scopus 로고
    • Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns
    • Hashimoto M, Asai Y, Ogawa T: Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J. Biol. Chem. 278(45), 44205-44213 (2003).
    • (2003) J. Biol. Chem , vol.278 , Issue.45 , pp. 44205-44213
    • Hashimoto, M.1    Asai, Y.2    Ogawa, T.3
  • 103
    • 0036143018 scopus 로고    scopus 로고
    • Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation
    • Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109(1), 41-50 (2002).
    • (2002) J. Clin. Invest , vol.109 , Issue.1 , pp. 41-50
    • Huynh, M.L.1    Fadok, V.A.2    Henson, P.M.3
  • 104
    • 38349136184 scopus 로고    scopus 로고
    • Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease
    • Crotty S, Fitzgerald P, Tuohy E et al.: Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease. Eur. J. Neurosci. 27(2), 294-300 (2008).
    • (2008) Eur. J. Neurosci , vol.27 , Issue.2 , pp. 294-300
    • Crotty, S.1    Fitzgerald, P.2    Tuohy, E.3
  • 105
    • 68649118090 scopus 로고    scopus 로고
    • A critical evaluation of the ubiquitin - proteasome system in Parkinson's disease
    • Cook C, Petrucelli L: A critical evaluation of the ubiquitin - proteasome system in Parkinson's disease. Biochim. Biophys. Acta (2009).
    • (2009) Biochim. Biophys. Acta
    • Cook, C.1    Petrucelli, L.2
  • 106
    • 54249153676 scopus 로고    scopus 로고
    • Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: Implications for Parkinson's disease
    • Fitzgerald P, Mandel A, Bolton AE, Sullivan AM, Nolan Y: Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease. Behav. Brain Res. 195(2), 271-274 (2008).
    • (2008) Behav. Brain Res , vol.195 , Issue.2 , pp. 271-274
    • Fitzgerald, P.1    Mandel, A.2    Bolton, A.E.3    Sullivan, A.M.4    Nolan, Y.5
  • 107
    • 65449172441 scopus 로고    scopus 로고
    • Functional protein delivery into neurons using polymeric nanoparticles
    • Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM: Functional protein delivery into neurons using polymeric nanoparticles. J. Biol. Chem. 284(11), 6972-6981 (2009).
    • (2009) J. Biol. Chem , vol.284 , Issue.11 , pp. 6972-6981
    • Hasadsri, L.1    Kreuter, J.2    Hattori, H.3    Iwasaki, T.4    George, J.M.5
  • 108
    • 44749092720 scopus 로고    scopus 로고
    • Solid lipid nanoparticles as delivery systems for bromocriptine
    • Esposito E, Fantin M, Marti M et al.: Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25(7), 1521-1530 (2008).
    • (2008) Pharm. Res , vol.25 , Issue.7 , pp. 1521-1530
    • Esposito, E.1    Fantin, M.2    Marti, M.3
  • 109
    • 33746493905 scopus 로고    scopus 로고
    • Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: A population-based study in southern Italy
    • Zoccolella S, Beghi E, Palagano G et al.: Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur. J. Neurol. 13(7), 789-792 (2006).
    • (2006) Eur. J. Neurol , vol.13 , Issue.7 , pp. 789-792
    • Zoccolella, S.1    Beghi, E.2    Palagano, G.3
  • 110
    • 34250209501 scopus 로고    scopus 로고
    • Amyotrophic lateral sclerosis
    • Mitchell JD, Borasio GD: Amyotrophic lateral sclerosis. Lancet 369(9578), 2031-2041 (2007).
    • (2007) Lancet , vol.369 , Issue.9578 , pp. 2031-2041
    • Mitchell, J.D.1    Borasio, G.D.2
  • 111
    • 33750457344 scopus 로고    scopus 로고
    • Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)
    • Qureshi MM, Hayden D, Urbinelli L et al.: Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph. Lateral Scler. 7(3), 173-182 (2006).
    • (2006) Amyotroph. Lateral Scler , vol.7 , Issue.3 , pp. 173-182
    • Qureshi, M.M.1    Hayden, D.2    Urbinelli, L.3
  • 112
    • 23144448320 scopus 로고    scopus 로고
    • Molecular and cellular pathways of neurodegeneration in motor neurone disease
    • Shaw PJ: Molecular and cellular pathways of neurodegeneration in motor neurone disease. J. Neurol. Neurosurg. Psychiatry 76(8), 1046-1057 (2005).
    • (2005) J. Neurol. Neurosurg. Psychiatry , vol.76 , Issue.8 , pp. 1046-1057
    • Shaw, P.J.1
  • 113
    • 60849093466 scopus 로고    scopus 로고
    • Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
    • Rothstein JD: Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65(Suppl. 1), S3-S9 (2009).
    • (2009) Ann. Neurol , vol.65 , Issue.SUPPL. 1
    • Rothstein, J.D.1
  • 114
    • 61449097436 scopus 로고    scopus 로고
    • Amyotrophic lateral sclerosis: A 40-year personal perspective
    • Eisen A: Amyotrophic lateral sclerosis: a 40-year personal perspective. J. Clin. Neurosci. 16(4), 505-512 (2009).
    • (2009) J. Clin. Neurosci , vol.16 , Issue.4 , pp. 505-512
    • Eisen, A.1
  • 115
    • 58149202714 scopus 로고    scopus 로고
    • Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress
    • Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V: Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl. Biochem. Biotechnol. 151(2-3), 565-577 (2008).
    • (2008) Appl. Biochem. Biotechnol , vol.151 , Issue.2-3 , pp. 565-577
    • Reddy, M.K.1    Wu, L.2    Kou, W.3    Ghorpade, A.4    Labhasetwar, V.5
  • 116
    • 55949103187 scopus 로고    scopus 로고
    • SOD activity of carboxyfullerenes predicts their neuroprotective efficacy: A structure - activity study
    • Ali SS, Hardt JI, Dugan LL: SOD activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure - activity study. Nanomedicine 4(4), 283-294 (2008).
    • (2008) Nanomedicine , vol.4 , Issue.4 , pp. 283-294
    • Ali, S.S.1    Hardt, J.I.2    Dugan, L.L.3
  • 117
    • 0033947469 scopus 로고    scopus 로고
    • Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation
    • Shibata N, Nagai R, Miyata S et al.: Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol. 100(3), 275-284 (2000).
    • (2000) Acta Neuropathol , vol.100 , Issue.3 , pp. 275-284
    • Shibata, N.1    Nagai, R.2    Miyata, S.3
  • 118
    • 56549114614 scopus 로고    scopus 로고
    • Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death
    • Cho Y, Shi R, Borgens RB, Ivanisevic A: Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. Nanomed. 3(4), 507-519 (2008).
    • (2008) Nanomed , vol.3 , Issue.4 , pp. 507-519
    • Cho, Y.1    Shi, R.2    Borgens, R.B.3    Ivanisevic, A.4
  • 119
    • 63649134784 scopus 로고    scopus 로고
    • Sensitive and colorimetric detection of the structural evolution of superoxide dismutase with gold nanoparticles
    • Hong S, Choi I, Lee S, Yang YI, Kang T, Yi J: Sensitive and colorimetric detection of the structural evolution of superoxide dismutase with gold nanoparticles. Anal. Chem. 81(4), 1378-1382 (2009).
    • (2009) Anal. Chem , vol.81 , Issue.4 , pp. 1378-1382
    • Hong, S.1    Choi, I.2    Lee, S.3    Yang, Y.I.4    Kang, T.5    Yi, J.6
  • 120
  • 121
    • 33745312709 scopus 로고    scopus 로고
    • Cognitive. dysfunction in multiple sclerosis: Assessment, imaging, and risk factors
    • Wallin MT, Wilken JA, Kane R: Cognitive. dysfunction in multiple sclerosis: Assessment, imaging, and risk factors. J. Rehabil. Res. Dev. 43(1), 63-72 (2006).
    • (2006) J. Rehabil. Res. Dev , vol.43 , Issue.1 , pp. 63-72
    • Wallin, M.T.1    Wilken, J.A.2    Kane, R.3
  • 122
    • 13944266747 scopus 로고    scopus 로고
    • Prelude to the framing of a disease: Multiple sclerosis in the period before Charcots Lecons
    • Murray J: Prelude to the framing of a disease: multiple sclerosis in the period before Charcots Lecons. Int. MS J. 11(3), 79-85 (2004).
    • (2004) Int. MS J , vol.11 , Issue.3 , pp. 79-85
    • Murray, J.1
  • 123
    • 23844506444 scopus 로고    scopus 로고
    • Multiple sclerosis pathology: Evolution of pathogenetic concepts
    • Lassmann H: Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol. 15(3), 217-222 (2005).
    • (2005) Brain Pathol , vol.15 , Issue.3 , pp. 217-222
    • Lassmann, H.1
  • 124
    • 0342906187 scopus 로고    scopus 로고
    • Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
    • Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47(6), 707-717 (2000).
    • (2000) Ann. Neurol , vol.47 , Issue.6 , pp. 707-717
    • Lucchinetti, C.1    Bruck, W.2    Parisi, J.3    Scheithauer, B.4    Rodriguez, M.5    Lassmann, H.6
  • 125
    • 64149103383 scopus 로고    scopus 로고
    • Pathophysiology of multiple sclerosis
    • Korn T: Pathophysiology of multiple sclerosis. J. Neurol. 255(Suppl. 6), (2008).
    • (2008) J. Neurol , vol.255 , Issue.SUPPL. 6
    • Korn, T.1
  • 126
    • 70249121764 scopus 로고    scopus 로고
    • Rojas JI, Romano M, Ciapponi A, Patrucco L, Cristiano E: Interfeon β for primary progressive multiple sclerosis. Cochrane Database Syst. Rev. 1, CD006643 (2009).
    • Rojas JI, Romano M, Ciapponi A, Patrucco L, Cristiano E: Interfeon β for primary progressive multiple sclerosis. Cochrane Database Syst. Rev. 1, CD006643 (2009).
  • 127
    • 44949141642 scopus 로고    scopus 로고
    • Clerico M, Faggiano F, Palace J, Rice G, Tintore M, Durelli L: Recombinant interferon β or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database Syst. Rev. 2, CD005278 (2008).
    • Clerico M, Faggiano F, Palace J, Rice G, Tintore M, Durelli L: Recombinant interferon β or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database Syst. Rev. 2, CD005278 (2008).
  • 128
    • 64149099359 scopus 로고    scopus 로고
    • Neuroprotection and neuroregeneration in multiple sclerosis
    • Stangel M: Neuroprotection and neuroregeneration in multiple sclerosis. J. Neurol. 255(Suppl. 6), 77-81 (2008).
    • (2008) J. Neurol , vol.255 , Issue.SUPPL. 6 , pp. 77-81
    • Stangel, M.1
  • 129
    • 34248657276 scopus 로고    scopus 로고
    • Remyelination in multiple sclerosis
    • Chari DM: Remyelination in multiple sclerosis. Int. Rev. Neurobiol. 79, 589-620 (2007).
    • (2007) Int. Rev. Neurobiol , vol.79 , pp. 589-620
    • Chari, D.M.1
  • 130
    • 54249124952 scopus 로고    scopus 로고
    • Remyelination in the CNS: From biology to therapy
    • Franklin RJ, Ffrench-Constant C: Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9(11), 839-855 (2008).
    • (2008) Nat. Rev. Neurosci , vol.9 , Issue.11 , pp. 839-855
    • Franklin, R.J.1    Ffrench-Constant, C.2
  • 131
    • 41849124231 scopus 로고    scopus 로고
    • Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
    • Basso AS, Frenkel D, Quintana FJ et al.: Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J. Clin. Invest. 118(4), 1532-1543 (2008).
    • (2008) J. Clin. Invest , vol.118 , Issue.4 , pp. 1532-1543
    • Basso, A.S.1    Frenkel, D.2    Quintana, F.J.3
  • 132
    • 33847609214 scopus 로고    scopus 로고
    • Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population
    • Li W, Minohara M, Su JJ et al.: Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J. Neuroimmunol. 184(1-2), 227-231 (2007).
    • (2007) J. Neuroimmunol , vol.184 , Issue.1-2 , pp. 227-231
    • Li, W.1    Minohara, M.2    Su, J.J.3
  • 133
    • 42749091150 scopus 로고    scopus 로고
    • Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis
    • Pezeshki MZ, Zarrintan S, Zarrintan MH: Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis. Med. Hypotheses 70(6), 1223 (2008).
    • (2008) Med. Hypotheses , vol.70 , Issue.6 , pp. 1223
    • Pezeshki, M.Z.1    Zarrintan, S.2    Zarrintan, M.H.3
  • 134
    • 64149123239 scopus 로고    scopus 로고
    • Immunosuppression in clinical practice: Approaches to individualized therapy
    • Chan A, Stuve O, von Ahsen N: Immunosuppression in clinical practice: approaches to individualized therapy. J. Neurol. 255(Suppl. 6), 22-27 (2008).
    • (2008) J. Neurol , vol.255 , Issue.SUPPL. 6 , pp. 22-27
    • Chan, A.1    Stuve, O.2    von Ahsen, N.3
  • 135
    • 34848926195 scopus 로고    scopus 로고
    • Immunosuppressive agents in multiple sclerosis
    • Neuhaus O, Kieseier BC, Hartung HP: Immunosuppressive agents in multiple sclerosis. Neurotherapeutics 4(4), 654-660 (2007).
    • (2007) Neurotherapeutics , vol.4 , Issue.4 , pp. 654-660
    • Neuhaus, O.1    Kieseier, B.C.2    Hartung, H.P.3
  • 136
    • 38349186321 scopus 로고    scopus 로고
    • Intense immunosuppression in patients with rapidly worsening multiple sclerosis: Treatment guidelines for the clinician
    • Boster A, Edan G, Frohman E et al.: Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician. Lancet Neurol.. 7(2), 173-183 (2008).
    • (2008) Lancet Neurol , vol.7 , Issue.2 , pp. 173-183
    • Boster, A.1    Edan, G.2    Frohman, E.3
  • 137
    • 34250816184 scopus 로고    scopus 로고
    • Fullerene nanomaterials inhibit the allergic response
    • Ryan JJ, Bateman HR, Stover A et al.: Fullerene nanomaterials inhibit the allergic response. J. Immunol. 179(1), 665-672 (2007).
    • (2007) J. Immunol , vol.179 , Issue.1 , pp. 665-672
    • Ryan, J.J.1    Bateman, H.R.2    Stover, A.3
  • 139
    • 34948863876 scopus 로고    scopus 로고
    • In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide
    • McAteer MA, Sibson NR, von Zur Muhlen C et al.: In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat. Med. 13(10), 1253-1258 (2007).
    • (2007) Nat. Med , vol.13 , Issue.10 , pp. 1253-1258
    • McAteer, M.A.1    Sibson, N.R.2    von Zur3    Muhlen, C.4
  • 140
    • 34250773901 scopus 로고    scopus 로고
    • Magnetic resonance imaging of human, brain macrophage infiltration
    • Petry KG, Boiziau C, Dousset V, Brochet B: Magnetic resonance imaging of human, brain macrophage infiltration. Neurotherapeutics 4(3), 434-442 (2007).
    • (2007) Neurotherapeutics , vol.4 , Issue.3 , pp. 434-442
    • Petry, K.G.1    Boiziau, C.2    Dousset, V.3    Brochet, B.4
  • 141
    • 33749039453 scopus 로고    scopus 로고
    • Risk factors for ischemic stroke subtypes: The Atherosclerosis Risk in Communities study
    • Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR: Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke 37(10), 2493-2498 (2006).
    • (2006) Stroke , vol.37 , Issue.10 , pp. 2493-2498
    • Ohira, T.1    Shahar, E.2    Chambless, L.E.3    Rosamond, W.D.4    Mosley Jr, T.H.5    Folsom, A.R.6
  • 142
    • 68149160611 scopus 로고    scopus 로고
    • Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury
    • Reddy MK, Labhasetwar V: Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J. 23(5), 1384-1395 (2009).
    • (2009) FASEB J , vol.23 , Issue.5 , pp. 1384-1395
    • Reddy, M.K.1    Labhasetwar, V.2
  • 143
    • 34250367839 scopus 로고    scopus 로고
    • Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides
    • Chen J, Patil S, Seal S, McGinnis JF: Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 1(2), 142-150 (2006).
    • (2006) Nat. Nanotechnol , vol.1 , Issue.2 , pp. 142-150
    • Chen, J.1    Patil, S.2    Seal, S.3    McGinnis, J.F.4
  • 145
    • 33846314024 scopus 로고    scopus 로고
    • Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons
    • Das M, Patil S, Bhargava N et al.: Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28(10), 1918-1925 (2007).
    • (2007) Biomaterials , vol.28 , Issue.10 , pp. 1918-1925
    • Das, M.1    Patil, S.2    Bhargava, N.3
  • 147
    • 34247563851 scopus 로고    scopus 로고
    • Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: Evaluation with photochemically induced thrombosis of the middle cerebral artery
    • Kawaguchi AT, Fukumoto D, Haida M, Ogata Y, Yamano M, Tsukada H: Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery. Stroke 38(5), 1626-1632 (2007).
    • (2007) Stroke , vol.38 , Issue.5 , pp. 1626-1632
    • Kawaguchi, A.T.1    Fukumoto, D.2    Haida, M.3    Ogata, Y.4    Yamano, M.5    Tsukada, H.6
  • 148
    • 57749201812 scopus 로고    scopus 로고
    • Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: Effect of oxygen affinity
    • Fukumoto D, Kawaguchi AT, Haida M, Yamano M, Ogata Y, Tsukada H: Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: effect of oxygen affinity. Artif. Organs 33(2), 159-163 (2009).
    • (2009) Artif. Organs , vol.33 , Issue.2 , pp. 159-163
    • Fukumoto, D.1    Kawaguchi, A.T.2    Haida, M.3    Yamano, M.4    Ogata, Y.5    Tsukada, H.6
  • 149
    • 58849160970 scopus 로고    scopus 로고
    • Liposome-encapsulated hemoglobin alleviates brain edema after permanent occlusion of the middle cerebral artery in rats
    • Kawaguchi AT, Kurita D, Furuya H, Yamano M, Ogata Y, Haida M: Liposome-encapsulated hemoglobin alleviates brain edema after permanent occlusion of the middle cerebral artery in rats. Artif. Organs 33(2), 153-158 (2009).
    • (2009) Artif. Organs , vol.33 , Issue.2 , pp. 153-158
    • Kawaguchi, A.T.1    Kurita, D.2    Furuya, H.3    Yamano, M.4    Ogata, Y.5    Haida, M.6
  • 150
    • 57749185892 scopus 로고    scopus 로고
    • In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography
    • Urakami T, Kawaguchi AT, Akai S et al.: In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography. Artif. Organs 33(2), 164-168 (2009).
    • (2009) Artif. Organs , vol.33 , Issue.2 , pp. 164-168
    • Urakami, T.1    Kawaguchi, A.T.2    Akai, S.3
  • 151
    • 9644272621 scopus 로고    scopus 로고
    • HIV dementia: An evolving disease
    • McArthur JC: HIV dementia: an evolving disease. J. Neuroimmunol. 157(1-2), 3-10 (2004).
    • (2004) J. Neuroimmunol , vol.157 , Issue.1-2 , pp. 3-10
    • McArthur, J.C.1
  • 152
    • 33644845025 scopus 로고    scopus 로고
    • Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases
    • Kadiu I, Glanzer JG, Kipnis J, Gendelman HE, Thomas MP: Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases. Neurotox. Res. 8(1-2); 25-50 (2005).
    • (2005) Neurotox. Res , vol.8 , Issue.1-2 , pp. 25-50
    • Kadiu, I.1    Glanzer, J.G.2    Kipnis, J.3    Gendelman, H.E.4    Thomas, M.P.5
  • 153
    • 0025787561 scopus 로고
    • Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, pediatric, and fetal brains
    • Kure K, Llena JF, Lyman WD et al.: Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum. Pathol. 22(7), 700-710 (1991).
    • (1991) Hum. Pathol , vol.22 , Issue.7 , pp. 700-710
    • Kure, K.1    Llena, J.F.2    Lyman, W.D.3
  • 154
    • 0029126868 scopus 로고
    • AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations
    • Brew BJ, Rosenblum M, Cronin K, Price RW: AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol. 38(4), 563-570 (1995).
    • (1995) Ann. Neurol , vol.38 , Issue.4 , pp. 563-570
    • Brew, B.J.1    Rosenblum, M.2    Cronin, K.3    Price, R.W.4
  • 155
    • 22744455058 scopus 로고    scopus 로고
    • HIV-1 infection and AIDS: Consequences for the central nervous system
    • Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA: HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12(Suppl. 1), 878-892 (2005).
    • (2005) Cell Death Differ , vol.12 , Issue.SUPPL. 1 , pp. 878-892
    • Kaul, M.1    Zheng, J.2    Okamoto, S.3    Gendelman, H.E.4    Lipton, S.A.5
  • 156
    • 53849134844 scopus 로고    scopus 로고
    • Cellular reservoirs of HIV-1 and their role in viral persistence
    • Alexaki A, Liu Y, Wigdahl B: Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 6(5), 388-400 (2008).
    • (2008) Curr. HIV Res , vol.6 , Issue.5 , pp. 388-400
    • Alexaki, A.1    Liu, Y.2    Wigdahl, B.3
  • 157
    • 66749103433 scopus 로고    scopus 로고
    • The transport of anti-HIV drugs across blood-CNS interfaces: Summary of current knowledge and recommendations for further research
    • Varatharajan L, Thomas SA: The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res. 82(2), A99-A109 (2009).
    • (2009) Antiviral Res , vol.82 , Issue.2
    • Varatharajan, L.1    Thomas, S.A.2
  • 158
    • 68249144974 scopus 로고    scopus 로고
    • NanoART, NeuroAIDS and CNS drug delivery
    • Nowacek A, Gendelman HE: NanoART, NeuroAIDS and CNS drug delivery. Nanomedicine 4(5), 557-574 (2009).
    • (2009) Nanomedicine , vol.4 , Issue.5 , pp. 557-574
    • Nowacek, A.1    Gendelman, H.E.2
  • 159
    • 51749096415 scopus 로고    scopus 로고
    • Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line
    • Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R: Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm. Res. 25(10), 2262-2271 (2008).
    • (2008) Pharm. Res , vol.25 , Issue.10 , pp. 2262-2271
    • Chattopadhyay, N.1    Zastre, J.2    Wong, H.L.3    Wu, X.Y.4    Bendayan, R.5
  • 160
    • 50849094554 scopus 로고    scopus 로고
    • TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
    • Rao KS, Reddy MK, Horning JL, Labhasetwar V: TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29(33), 4429-4438 (2008).
    • (2008) Biomaterials , vol.29 , Issue.33 , pp. 4429-4438
    • Rao, K.S.1    Reddy, M.K.2    Horning, J.L.3    Labhasetwar, V.4
  • 161
    • 34447268486 scopus 로고    scopus 로고
    • Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles
    • Kup YC, Su FL: Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int. J. Pharm. 340(1-2), 143-152 (2007).
    • (2007) Int. J. Pharm , vol.340 , Issue.1-2 , pp. 143-152
    • Kup, Y.C.1    Su, F.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.